Lundbeck presents Phase 1b data for Parkinson's drug at conference
Tweet Send to a Friend
H. Lundbeck A/S announced it will present Phase 1b trial data for Lu AF28996, an investigational treatment for advanced Parkinson's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
